EPO and chronic kidney disease: Recently, Kobayashi et al. suggested that Epo is lost during CKD progression due to the progressive loss of areas containing functional REP cells and that phlebotomy or PHD inhibition re-induced Epo in REP cells residing in preserved areas of the otherwise damaged kidneys [54].